The probiotic industry has seen significant innovations, particularly in enhancing the effectiveness and delivery of beneficial microorganisms. Advances include the development of targeted probiotic strains that offer specific health benefits, such as improved digestion or immune support. Innovations in encapsulation technology now protect probiotics from harsh stomach acids, ensuring more viable bacteria reach the intestines. Additionally, new prebiotic formulations are designed to better support probiotic growth, with ingredients that enhance their effectiveness and stability. The industry is also exploring personalized probiotics, tailored to individual gut microbiomes for more precise health benefits. These advancements are pushing the boundaries of how probiotics and prebiotics can contribute to wellness, making them more accessible and effective in addressing various health needs.
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India